Revvity, Inc. (NYSE:RVTY) Shares Purchased by E Fund Management Co. Ltd.

E Fund Management Co. Ltd. boosted its stake in Revvity, Inc. (NYSE:RVTY) by 92.5% during the 4th quarter, HoldingsChannel reports. The fund owned 3,166 shares of the company’s stock after buying an additional 1,521 shares during the period. E Fund Management Co. Ltd.’s holdings in Revvity were worth $353,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in RVTY. EdgePoint Investment Group Inc. raised its holdings in Revvity by 34.6% in the third quarter. EdgePoint Investment Group Inc. now owns 2,685,775 shares of the company’s stock valued at $343,108,000 after acquiring an additional 690,534 shares in the last quarter. Southpoint Capital Advisors LP bought a new stake in Revvity during the third quarter valued at $25,550,000. Proficio Capital Partners LLC increased its stake in Revvity by 12,298.3% during the fourth quarter. Proficio Capital Partners LLC now owns 195,769 shares of the company’s stock valued at $21,850,000 after purchasing an additional 194,190 shares during the last quarter. Janus Henderson Group PLC increased its stake in Revvity by 1.7% during the third quarter. Janus Henderson Group PLC now owns 6,335,302 shares of the company’s stock valued at $809,332,000 after purchasing an additional 108,401 shares during the last quarter. Finally, Holocene Advisors LP increased its stake in Revvity by 14.6% during the third quarter. Holocene Advisors LP now owns 725,917 shares of the company’s stock valued at $92,736,000 after purchasing an additional 92,240 shares during the last quarter. 86.65% of the stock is owned by institutional investors and hedge funds.

Revvity Stock Performance

Shares of RVTY opened at $117.95 on Friday. The firm has a 50-day moving average price of $116.90 and a 200 day moving average price of $118.23. The firm has a market capitalization of $14.17 billion, a PE ratio of 53.37, a P/E/G ratio of 3.82 and a beta of 1.06. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. Revvity, Inc. has a 52-week low of $97.32 and a 52-week high of $129.50.

Revvity (NYSE:RVTY) last announced its earnings results on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period last year, the firm posted $1.25 earnings per share. On average, sell-side analysts anticipate that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be given a $0.07 dividend. The ex-dividend date is Thursday, April 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.24%. Revvity’s dividend payout ratio is presently 12.67%.

Insider Activity at Revvity

In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the completion of the sale, the insider now directly owns 33,400 shares of the company’s stock, valued at approximately $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Tajinder S. Vohra sold 5,492 shares of the company’s stock in a transaction dated Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total transaction of $641,520.52. Following the sale, the insider now directly owns 19,652 shares of the company’s stock, valued at $2,295,550.12. This represents a 21.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

RVTY has been the subject of several recent research reports. Barclays boosted their target price on shares of Revvity from $135.00 to $140.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Bank of America upgraded shares of Revvity from a “neutral” rating to a “buy” rating and set a $138.00 target price for the company in a research note on Friday, December 13th. KeyCorp boosted their target price on shares of Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Raymond James reiterated an “outperform” rating and set a $145.00 target price (up previously from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Finally, Sanford C. Bernstein lowered shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 target price for the company. in a research note on Friday, January 10th. Four equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $136.25.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.